Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts
Abstract Objective Malignant peripheral nerve sheath tumors (MPNST) are aggressive sarcomas characterized by high recurrence rates and early metastases. These tumors arise more frequently within neurofibromatosis type 1 (NF1) and present with resistance during standard chemotherapy leading to increa...
Main Authors: | Susan Fischer-Huchzermeyer, Levan Chikobava, Verena Stahn, Monique Zangarini, Philip Berry, Gareth J. Veal, Volker Senner, Victor F. Mautner, Anja Harder |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-07-01
|
Series: | BMC Research Notes |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13104-018-3630-0 |
Similar Items
-
MEK inhibitors enhance therapeutic response towards ATRA in NF1 associated malignant peripheral nerve sheath tumors (MPNST) in-vitro.
by: Susan Fischer-Huchzermeyer, et al.
Published: (2017-01-01) -
Factors Within the Endoneurial Microenvironment Act to Suppress Tumorigenesis of MPNST
by: Jo Anne Stratton, et al.
Published: (2018-10-01) -
Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus with MEK Inhibitor Trametinib in Some BRAF or KRAS-Mutated Colorectal or Lung Carcinoma Models
by: XuSha Zhou, et al.
Published: (2021-09-01) -
Surgical strategies and the use of functional reconstructions after resection of MPNST: An international survey on surgeons’ perspective
by: Enrico Martin, et al.
Published: (2021-06-01) -
Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model
by: Christian Linke, et al.
Published: (2020-09-01)